Evidence map›Paper›PMID 19020755›Full record

ArticleInternational journal of oncology2008

Activation of Notch signaling in human colon adenocarcinoma.

Michael Reedijk, Silvia Odorcic, Hui Zhang, Runjan Chetty, Carsten Tennert, Brendan C Dickson, Gina Lockwood, Steven Gallinger, Sean E Egan

Open access · bronzeAbstract readMulticenter Study
In one paragraph

Article in International journal of oncology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 105 papers.

0numbers the graph read from it
0cells of the map it votes in
105citing papers in PubMed
–field-weighted citation impact, top 81% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

105 citing papers in PubMed, 211 citations in OpenAlex.

  1. Trial
  2. A phase II study of RO4929097 in metastatic colorectal cancer.European journal of cancer (Oxford, England : 1990) · 2012
    Trial
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. A concise review on miRNAs as regulators of colon cancer stem cells and associated signalling pathways.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2023
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

45 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Michael ReedijkProgram in Developmental Biology and Stem Cell Research, The Hospital for Sick Children, MaRS East Tower, Ontario M5G 1L7, Canada.
Silvia Odorcic
Hui Zhang
Runjan Chetty
Carsten Tennert
Brendan C Dickson
Gina Lockwood
Steven Gallinger
Sean E Egan
SickKids Foundation · CA

Funding

ONTARIO REGISTRY FOR STUDIES OF FAMILIAL COLON CANCERU01CA074783 · NCI · CANCER CARE ONTARIO · PI GALLINGER, STEVEN · 1997 to 2008
$12.5M
The Colon Cancer Family Registry: OntarioU24CA074783 · NCI · CANCER CARE ONTARIO · PI GALLINGER, STEVEN · 2008 to 2011
$4.1M
NCI NIH HHS RFA#CA-96-011NCI NIH HHS U01 CA074783NCI NIH HHS U24 CA074783
6 · The paper itself

Abstract

Notch and Wnt signaling function together to regulate colonic progenitor cell division and differentiation. Studies in mice have also shown that Notch signaling is required for adenoma formation in response to elevated Wnt-pathway signaling that occurs in the APCMin mouse model of human adenomatous polyposis coli. We therefore used in situ hybridization to analyze expression of Notch ligands, receptors and fringe genes, as well as the Notch target gene, HES1, in human colorectal cancer (CRC). In a small cohort of tumors, JAGGED ligands, NOTCH1, LFNG and HES1 were expressed at levels similar to, or higher than, levels observed in the crypt. To explore the possibility that Notch signaling may play a quantitative role in human CRC we next analyzed HES1 mRNA expression in 130 tumors, each associated with outcome data. The vast majority of these tumors expressed HES1, although at varying levels. Absolute expression levels did not correlate with patient survival. These results establish that JAG ligands and NOTCH1, as well as Notch receptor activation are consistent features of human CRC and support the notion that many of these tumors, like the APCMin mouse, may respond to anti-Notch therapeutic regimes.

Indexed as

Gene Expression Regulation, NeoplasticAdenocarcinomaBasic Helix-Loop-Helix ProteinsCalcium-Binding ProteinsCell DifferentiationColonic NeoplasmsGermanyGlycosyltransferasesHomeodomain ProteinsHumansIn Situ HybridizationIntercellular Signaling Peptides and ProteinsJagged-1 ProteinKaplan-Meier EstimateMembrane ProteinsOntarioBasic Helix-Loop-Helix ProteinsCalcium-Binding ProteinsGlycosyltransferasesHES1 protein, humanHomeodomain ProteinsIntercellular Signaling Peptides and ProteinsJAG1 protein, humanJag1 protein, mouseJagged-1 ProteinLFNG protein, humanMembrane ProteinsNOTCH1 protein, humanReceptor, Notch1Receptors, NotchRNA, MessengerSerrate-Jagged ProteinsTranscription Factor HES-1

Identifiers

PMID19020755
PMCPMC2739737
OpenAlexW2168833693

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.